INTRODUCTION
Ovarian cancer is the most lethal gynaecological cancer. Worldwide, 2,39,000 new cases of ovarian cancer and estimated deaths of 1,52,000 are recorded in 2014. 1 Age adjusted incidence rates(AAR) ranged from 11 per 100000 women in Central Europe to 5 per 100000 women in Africa. 2 . Estimated new cases and deaths of ovarian cancer in the United States in 2015 is 21,290 and 14,180 with lifetime risk of about 1.33% and AAR of 11.4 per100000 women. 3 In England and Wales, it is fifth most common cancer with estimated life time risk of 1.66% and AAR of 9.4 per 100000 population. 4 It is the fourth most common cancer in women in India. 5 Indian cancer registry data in 2011 projects AAR of ovarian cancer from 10.7-1.2 per100000 in different parts of the country with the highest incidence in Kamrup urban district and Delhi registries.
In spite of all the advances made in diagnosis and treatment, ovarian carcinoma remains the leading cause of gynaecological disease mortality. The ovaries are relatively inaccessible with unknown precursor lesions. It is a heterogeneous disease with low and high grade subtypes and widely differing clinicopathologic features which develop independently along different molecular pathways. Both types develop outside the ovary and involve it secondarily. This explains why current screening strategies designed to detect ovarian cancer, when it is confined to the ovary, are ineffective in accomplishing this goal. 7 So this study was undertaken in view of importance of clinicopathological determination in diagnosis, prognosis as well as appropriate management of ovarian tumours at our tertiary care referral hospital.
METHODS
This was a 5 years observational study from September 2009 to August 2014 in the Department of Obstetrics and Gynaecology, Rangaraya Medical College, Kakinada, AP, South India. All cases with ovarian mass lesions treated surgically were included in the study. The diagnostic evaluation was done with investigations for exclusion of malignancy with USG, tumour markers, CT and MRI wherever indicated. Clinical details of the patients included age, gynaecological &obstetric history, presenting symptoms, and surgery details. Histopathalogical reporting was done at our Pathology department. The lesions were categorised as non-neoplastic and neoplastic and analysed. The histological characterisation of ovarian tumour was done according to World Health Organization Classification of Ovarian tumours.
Statistical Methods
Descriptive statistics and Pearson Chi-square test were used to describe the study sample with Microsoft Excel software and SPSS 16.
RESULTS
Incidence of ovarian masses was 4.66 % (n=404) in 8,656 admissions subjected to surgery. 84.16% were neoplastic, 15.84% non-neoplastic. Among neoplasms (248/340) 72.94% were benign tumours, 26(7.64%) were borderline and 66(19.41%) were malignant ovarian tumours ( Figure  1) . Age of the patients ranged from 9years to 82 years. Mean ages for non-neoplastic, benign and malignant were 35.9, 36.8, and 44.7 years. Benign lesions were more common in 30-40years, and malignant lesions in 40-59 years age (Table 1) . Non neoplastic lesions were 64 (15.84%) with follicular cyst as commonest ( Figure 2 ). Twisted ovarian cyst with both non-neoplastic and neoplastic tumours was the commonest surgical emergency (5.91%), followed by ruptured corpus luteal cysts (1.33%). There were 2 cases of torsion in the adolescents and 20 cases in the reproductive women in whom one was antenatal, two puerpural, one case was in postmenopausal age group ( Figure 3 ).
Non neoplastic
Demographic & clinical Profile of patients is shown in ( Table 2 ). The commonest presenting symptom was pain abdomen and mass abdomen and menstrual abnormalities in non-neoplastic and benign neoplasms. Vague abdominal and constitutional symptoms were more in malignant cases. Thyrotoxicosis, virilisation, hirsutism hoarseness of voice, menstrual abnormalities including postmenopausal bleeding were more in hormone secreting sex cord stromal and germ cell tumours. Pleural effusion was seen with fibroma (Table 3) . Surface epithelial tumours were 78.12% (268/340) dominated others, with commonest benign neoplasm as mucinous cystadenoma 34.11% (116/340) followed by serous cystadenoma 25.29% (86/340) and malignant as serous cystadenocarcinoma (9.95%), mucinous cystadenocarcinoma (2.72%). There were 2 cases of malignant Brenner tumour and one endometroid tumour. Germ cell tumours formed (41/340) 12.05%, majority (80%) of cases were benign mature cystic teratomas. The malignant germ cell tumours were 6(1.76%) cases of dysgerminoma, and 3(0.88%) cases of endodermal sinus tumor. Sexcordstromal tumors were 6.47%, with 6 cases granulosa cell & one sertolileydig as malignant and seven cases each of fibromas, fibrothecomas as benign. One metastasis was from colonic carcinoma ( Table 4 ).
Most of the Germ cell tumours were diagnosed at early stage and all the Surface epithelial tumors were diagnosed mostly in stage III and IV (84%). For malignant neoplasms surgical staging laparotomy (TAH with BSO and omentectomy) was done in 16 cases, debulking and chemotherapy in 24 cases, neo-adjuvant chemotherapy with cytoreductive surgery in 6cases and palliative chemotherapy in 4 cases. 6 cases were operated for recurrence. Fertility-sparing surgical measures, such as unilateral salpingo-oophorectomy was done in stage 1 tumours in juvenile granulosa cell tumours, yolksac tumour in adolescents and also in one case of Sertolileydig cell tumour, who delivered at term gestation. Follow up of malignant ovarian tumours was inadequate with reported 12 deaths. [12] [13] [14] [15] [16] is shown in Table 5 .
Non-neoplastic lesions are the common causes of ovarian enlargement with possibly hormonally active follicular and luteal cysts or inactive serous cysts as classified by Blaustein. 17 . In our study follicularcysts (37.15%) were most common followed by simple serous(30%), endometriotic cysts (9.37%), corpusluteal cysts (7.80%). In other studies luteal cysts, endometriotic cysts were common followed by simple serous cyst, [8] [9] [10] follicular and corpus luteal cysts were common followed by serous cysts. 11, 13 Twisted ovarian cyst was commonest surgical emergency in 23 cases (5.91%) followed by cyst rupture and haemoperitoneum (3.12%). S. Maharjan 10 observed torsion (6.7%), but higher incidence of cysts rupture with haemoperitoneum (6%) than in our study. Torsion was present in 65% cases of neoplasms and 35% cases of nonneoplastic lesions in our study. Cass et al. 18 observed torsion in 55% neoplasms and 47% non-neoplastic lesions and Manivasakan et al. 19 observed in 45% and 53% respectively.
Our study reveals that the presentation of ovarian tumours is variable. Common symptoms were abdominal mass, pelvic/abdominal pain. Other symptoms are dyspepsia, urinary frequency and urgency, loss of weight and ascites, which are more common in malignant tumours. These findings are in accordance to other studies. [8] [9] [10] [11] [12] [13] [14] [15] [19] [20] [21] Benign lesions were more common in 30-40 years, and malignant lesions in 40-59 years age group similar to studies of Ameena, Jha. 8, 20 The commonest neoplasms were epithelial tumours seen 12-80 years with peak age at 41-50 yrs. Mean age of malignant tumors is 44.7 years which is nearer to study of Sharada, Bist, Iyoke 9, 14, 21 between 41-45.4 yr. This is lower than median age of 64yearsin USA. The variance in age groups being lower in Asians was also observed by Katherine C.Fuh.
22
Despite the high incidence and mortality rates, the etiology of ovarian cancer is poorly understood. Established risk factors for ovarian cancer include age and having a family history, while protective factors include increasing parity, oral contraceptive use, and oophorectomy. Borderline and malignant tumours were (73.08%) & (50%) in reproductive age group (P< 0.001), and more tumours in multiParity (P<0.001) was statistically significant. There was no family history in malignant neoplasms in our study. There was no history of harmone replacement therapy. Protective effect of multiparity, tubal sterilization and hysterectomy were not significant in our study. Surgeries such as hysterectomy and tubal ligation are said to confer a weak protective effect against ovarian cancer from ascending carcinogens. 23 . Women with ovarian preservation at hysterectomy are at risk for future oophorectomy, which ranges from 2.9% to 7.7%. 24 There has been a growing evidence supporting the fallopian tube as the site of origin of high grade surface epithelial ovarian cancer. The latest opinion of ACOG, 2015 is prophylactic salpingectomy may offer protection instead of oopherectomy in at risk cases of ovarian cancer without hypoestrogenic effects. 25 In our study surface epithelial tumors were commonest, followed by germ cell tumors, sex cord stromal tumors.
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Benign surface epithelial tumors were the commonest type (81.17%) followed by malignant surface epithelial tumour (15.88%) comparable to other studies 12, 16, 27 but with more borderline ovarian tumors 26(7.64%) similar to Mondal. 26 The suface epithelial tumours are subtyped into serous, mucinous, transitional, clear cell, endometroid types. Serous subtype epithelial tumours are commonest benign and malignant neoplasms in literature and various studies. 8-12,14,15,17,19-27 &others Mucinous tumours account for 10-15% of ovarian tumours but in our study mucinous cystadenomas dominated serous cystadenomas, comprising (139/340) 40.88% with benign 80.64%, 12.82% borderline and 6.9% carcinomas. No comparative literature was found with respect to increase in benign mucinous cystadenomas (Table 6 ). Mucinouscystadenocarcinoma was 6.1% in Ivy sharma. 28 study, but less than 4% in others. 26, 35, 36 This diversity may reflect the geographical and ethnic variations as epithelial ovarian cancer is a disease with a pattern of heterogeneous distribution. 29 In our study the exact cause of risk factors ,which may be environmental have to be studied further. Mucinouscystadenomas are associated with dermoid cysts in 3 to 5%, 30 suggesting that they may be monodermal teratomas of germ cell origin. In our study 2 cases of mucinous cystadenomas are associated with a dermoid, also reported by others. 31, 32 In our study they were mostly unilateral. They were not subtyped as endocervical and intestinal type. Appedicectomy was also done in 6 cases of mucinous neoplasms and no secondaries were diagnosed. These tumors are related closely to each other and are distinct from other histologic subtypes of epithelial ovarian neoplasms from a clinical, histologic, and also in mutational profiles such as KRAS mutations, but infrequent p53 and BRCA mutations. A continuum appears to be present from benign to borderline to malignant, which is different from other types of epithelial ovarian cancer, which suggests the potential preventability of borderline and invasive mucinous ovarian cancer by surgical excision of identifiable precursor lesions. 33 In our study there were no mucinouscystadenocarcinomas with malignant transformations. There were 2 cases of endometroid and 2 malignant Brenner tumours (0.57%) with no clear cell carcinoma, similar to study of. 34 Second most common group of ovarian neoplasms, are germ cell tumours. They are counterpart of testicular germ cell tumours. In our study they are 12.05%, consistent with other studies 15, 27, 35 lower than than in studies of others. 8, 11, 14, 16, 26 Mature cystic teratoma was the commonest type of germ cell tumour (80%) similar to other studies. 15 It was commonest benign tumour in study by Ameena, Bist and Jha, Pili. 8, 14, 20, 36 Dysgerminomas accounted to 1.76 % in our study, nearer to others. 16, 34, 35 Maharajan 10 reported dysgerminoma as the commonest malignant ovarian tumour . Functional teratomas such as strumaovari was seen 2 cases, also reported in other studies. 16, 37, 38 Torsion was seen in 18.52%.
Sex-cord stromal tumours represent approximately 7%of ovarian neoplasms, arises from mesenchymal components like steroid producing cells as well as fibroblasts, manifests as unilateral solid mass similar to testicular tumours. Harmonal manifestations are with estrogen producing granulosa cell tumours, testosterone producing SertoliLeydig cell tumours. Fibromas are harmonally inert but can produce complications like torsion and pleural effusion. 39 These were observed inour study. Torsion occured in 3.76% in fibromas and fibrothecomas and one case of fibroma presented with pleural effusion. Granulosa cell tumour is the most common oestrogen-producing ovarian tumour. Synchronous endometrial malignancy and endometrial hyperplasia can occur. 39 . In our study, there were both juvenile and adult granulosa cell tumours with menstrual irregularities and postmenopausal bleeding, the incidence of was 6.47%similar to other studies. 11, 15, 16, 20, 27, 36 One case of synchronous endometrial carcinoma was diagnosed, also reported in other studies. 16, 27, 39 . In our study there was a case of Sertolileydig cell tumour, conceived after surgery and delivered at term. Metastases to the ovaries are relatively frequent with the most common being from the endometrium, breast, colon, stomach, and cervix. 39 In our study there was one metastasis was from colonic carcinoma.
Late stage presentation was encountered in 86% of epithelial carcinomas (Stage III-IV). Delay in presentation is probably responsible for high mortality associated with the disease. Similar delays have been reported in other studies. 9,12-14,16,27,,39,40 Greater awareness among both women with disease and healthcare professionals might result in women presenting earlier with less advanced disease and treatment, leading to better outcomes.
Several limitations of our study deserve comment .This study is institutional based, the study group being small. Therefore, the results obtained may or may not reflect the actual histological pattern and age distribution of ovarian tumours in all Indian women, needs a large group multicentric study. 
CONCLUSION
The ovarian tumours in our institute represented a wide histological spectrum, commonest being surface epithelial tumours with a similar incidence to other studies .Mucinous cystadenomas subtype was more common than serous cystadenomas, an important implications for research approaches to early detection, prevention and treatment. Amongst malignant ovarian tumours younger age of presentation, advanced stages of the disease is more common, emphasizes the need for investigating for exclusion of malignancy in all the age groups.
